cytena GmbH was founded in 2014 as a spin-off from the Microsystems Technology Institute of the University of Freiburg and is a life-science company headquartered in Freiburg im Breisgau. The company develops, manufactures and sells laboratory instruments and software — primarily single-cell dispensers, live-cell imaging systems and plate-washing solutions — and provides related services; product families mentioned include X.SIGHT, CELLCYTE and C.WASH. In 2018 cytena established a subsidiary (cytena Bioprocess Solutions) in Taiwan and has been a 100% subsidiary of BICO Group AB since 2019; its products are used notably in drug development for biologicals, in clonal cell line development (CLD) and in gene and cell therapies. The report notes the market launch of third-generation single-cell dispensers (B.SIGHT, F.SIGHT OMICS), the introduction of the C.STATION, and that 48 employees worked in R&D in 2022.
Die Entwicklung, die Fertigung, der Betrieb und die Vermarktung von Geräten und Software, insbesondere auf dem Gebiet der Labor- und Medizintechnik und damit verbundene Dienstleistungen.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 711600 (as of 15 October 2026)
| Name | Type | City |
|---|---|---|
| Petros Apostolopoulos | Geschäftsführer(in) | Stuttgart |
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 711600 (as of 15 October 2026)
| Date | Event Type | Event |
|---|---|---|
| 19.01.2024 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| 30.04.2022 | Registered Seat Change | Neue |
| 30.04.2022 | Business Address Change | Zollhallenstraße 5, 79106 Freiburg im Breisgau |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 01.10.2018 | Capital Increase | +11.538 € | 78.461 € |
| 08.05.2015 | Capital Increase | +16.923 € | 66.923 € |
| 30.06.2014 | Share Capital Set | — | 50.000 € |
| Date | Contract | Value |
|---|---|---|
| 19.10.2026 | Supplier · Universität Bielefeld | 309.971 € |
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 711600 (as of 15 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2022 | €18,225,243 | -€16,237,709 | €30,842,168 | — |
| 2021 | €12,585,937 | -€2,641,236 | €24,720,593 | — |
| 2020 | — | -€295,382 | €6,839,937 | — |
| 2019 | — | €175,149 | €6,186,155 | — |
| 2018 | — | €141,922 | €5,244,841 | — |
| 2017 | — | €66,767 | €1,842,447 | — |
| 2016 | — | €23,212 | €1,540,501 | — |
Sign in to download data
Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 711600 (as of 15 October 2026)
Ovesco Endoscopy AG
Tübingen · Herstellung von Bestrahlungs- und Elektrotherapiegeräten und elektromedizinischen Geräten
medavis GmbH
Karlsruhe · Entwicklung und Programmierung von Anwendungssoftware
Saegeling Medizintechnik Service- und Vertriebs GmbH
Heidenau · Herstellung von Bestrahlungs- und Elektrotherapiegeräten und elektromedizinischen Geräten
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €8,346,165 | 35.5% |
| Material Costs | €9,009,216 | 38.4% |
| Depreciation | €5,601,830 | 23.9% |
| Interest & Similar | €520,098 | 2.2% |
